BioWorld - Wednesday, April 1, 2026

BioWorld Science

Aug. 19, 2021

View Archived Issues

YAP/TEAD expression defines distinct vulnerabilities in binary pan-cancer groups

Read More

Phase II topline data show efficacy of MS-1819 plus PERT in severe exocrine pancreatic insufficiency

Read More

DSG3-CAART cells safe in second cohort of DesCAARTes phase I trial

Read More

Brexpiprazole does not meet primary endpoint in borderline personality disorder trial

Read More

Assembly Biosciences to advance anti-HBV agent ABI-4334 to the clinic

Read More

Eisai describes new compounds for malaria

Read More

Roche discloses new antibacterials

Read More

Phenex Pharmaceuticals presents new AhR antagonists

Read More

New anti-MDR1 antibodies discovered by Kenjockety Biotechnology

Read More

Green light for UB-421 phase II studies in Taiwan and China for HIV

Read More

TCF7L2 gene variants linked to thoracic aortic aneurysm

Read More

APVO-436 may benefit patients with AML and MDS, first-in-human data suggest

Read More

First patient enrolled in trial on sirolimus drug-eluting balloon for erectile dysfunction

Read More

Viral-trapping icosahedral shells devised as broad-spectrum antiviral platform

Read More

TT-00420 enters phase I/II trial for advanced solid tumors

Read More

"Not just the flu" holds for SARS-CoV-2 long-term effects, too

Read More

Well Marker Bio starts phase I study of WM-S1-030 for solid tumors

Read More

COM-902 derivative AZD-2936 enters the clinic for non-small cell lung cancer

Read More